Vitamin C Study Fails to Improve Sepsis Outcomes
A study published in JAMA suggests that treatment with vitamin C, in addition to thiamine and hydrocortisone, does not improve treatment outcomes in hospitalized patients with sepsis.
New Search
If you are not happy with the results below please do another search
Search
50 search results for:
New York officials downplay concern over new coronavirus variant
/in African-Americans, California, Clinical Trials, Covid-19 Variant, COVID-19 Variant B.1.526 (New York), Hospitalized COVID-19 Patients, Mayor Bill de Blasio, New York City, R&D, Reuters Tally, South African Variant B.1.351, United StatesMayor Bill de Blasio’s chief medical adviser on Feb. 25 downplayed the results of two studies suggesting that a new coronavirus variant found in New York City in November will be more resistant to vaccines now being administered.
FDA allows storage, transport of Pfizer COVID-19 vaccine at higher temperatures
/in BioNTech, BNT162b2 (Pfizer and BioNTech), Center for Biologics Evaluation and Research (CBER), COVID-19 vaccine storage temperatures, COVID-19 Vaccines, FDA, PfizerThe U.S. Food and Drug Administration on Feb. 25 approved storage and transportation of COVID-19 vaccine developed by Pfizer Inc. and German partner BioNTech SE at standard freezer temperatures for up to two weeks instead of ultra-cold conditions.
Q&A with Klick’s Lori Grant, Greg Rice and Ari Schaefer
/in Appointments, Expansion, Healthcare Communications Agencies, Marketing & Advertising, New Hires, New Offerings, People on the Move, PromotionsMed Ad News talked with Klick Health CEO Lori Grant and new Co-Presidents Greg Rice and Ari Schaefer about the recent appointment of Rice and Schaefer; the introduction of new business units; what clients are seeking from the company; and Klick’s work during the pandemic.
Fishawack Health Appoints Deborah Keller as Chair
/in Appointments, Business, Life Sciences, Marketing & Advertising, People on the MoveFishawack Health, a leading commercialization partner for the life science industry, appointed former Covance CEO Deborah Keller as the new Chair of its board.
FDA Approves Humira for Pediatric Ulcerative Colitis
/in AbbVie, Approvals, Blockbusters, Clinical Trials, FDA, Inflammatory Bowel Disease, New Indications, Pediatric Ulcerative Colitis, R&D, TherapeuticsThe U.S. Food and Drug Administration approved AbbVie’s biologic therapy Humira (adalimumab) as a treatment for moderate-to-severe active ulcerative colitis in children aged 5 years and older.
Experts Study Use of Covid-19 Vaccine Boosters to Fight Emerging Variants
/in COVID-19 cases, COVID-19 Vaccines, Health Experts, Johns Hopkins University School of MedicineSARS-CoV-2 continues to mutate while spreading around the world – infecting more than 112.7 million people as of Feb. 25, according to the Johns Hopkins University of Medicine Covid-19 Dashboard – as companies such as Pfizer and Moderna evaluate boosters against new variants of the virus.
Merck Snaps Up Pandion in $1.85 Billion Deal
/in Acquisitions, Autoimmune Diseases, Business, Clinical Trials, Deals, Immune Modulation, R&D, Shares, Stocks, Trading, Ulcerative ColitisShares of Pandion Therapeutics soared more than 131 percent in trading after pharma giant Merck announced the acquisition of the autoimmune-focused company for up to $1.85 billion.
Bahrain first country to approve J&J Covid-19 vaccine for emergency use
/in Johnson & JohnsonBahrain approved Johnson & Johnson’s one-dose Covid-19 vaccine for emergency use, the first country to do so, the National Health Regulatory Authority (NHRA) said on Feb. 25.
Regeneron to stop giving placebo in Covid-19 drug trial after ‘clear efficacy’
/in Clinical Trials, Hospitalized COVID-19 Patients, Placebo, R&D, Regeneron PharmaceuticalsRegeneron Pharmaceuticals said an independent panel found the company’s Covid-19 antibody cocktail to have “clear clinical efficacy” in reducing the rates of hospitalization and deaths in patients.